THE COMPANY
Medasense Biometrics Ltd. is a seed-stage medical device company that develops the PMD - Pain Monitoring Device, a novel tool, which acquires in a non-invasive way, processes and uses multidimensional analysis of physiological signals in order to monitor the pain level.

BACKGROUND
The assessment of pain is critical to ensure effective ongoing patient care. Currently pain is measured only by the patient subjective statement that describes the pain in scale between 1-10 (whenever the patients can communicate) or based on the vital signs and some other visual signs such as skin color, unstable movement, shivering (when the patient cannot communicate).

THE NEED
Previous studies confirm that protocols using valid and reliable scoring systems can minimize the use of medicines for sedation and analgesia and thereby decrease patient recovery time, decrease the risk of side effects and reduce direct and in-direct costs[1]. Therefore there is a need for monitoring system with objective scale for diagnostic and tracking of the pain level.

PMD
The significant advantage of PMD over other pain monitoring solutions is its reliable and far more accurate measurement of the patient's pain level. The company uses its unique algorithmic core ability and apply modern computational approaches never been used in the area of pain monitoring.
 
[1] Effect of nursing-implemented sedation protocol on the duration of mechanical ventilation”, Brook et al., 1999 “Daily interruption of sedative infusions in critically ill patients undergoing mechanical ventilation” , Kreiss et al 2000 “Pharmacoeconomic impact of rational use guidelines on the provision of analgesia, sedation, and neuromuscular blockade in critical care”, Mascia, Koch, & Medicis, 2000